| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/29/2008 | CA2295321C Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
| 01/29/2008 | CA2290446C Method and compositions for administering taxanes orally to human patients |
| 01/29/2008 | CA2267651C Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/28/2008 | CA2613172A1 Nutritional formulations containing octenyl succinate anhydride-modified tapioca starch |
| 01/24/2008 | WO2008011364A2 Quercetin-containing compositions |
| 01/24/2008 | WO2008011363A2 Quercetin-containing compositions |
| 01/24/2008 | WO2008011110A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 01/24/2008 | WO2008011107A2 Antagonists of protease activated receptor-1 (par1) |
| 01/24/2008 | WO2008011081A2 Wsx-1/p28 as a target for anti-inflammatory responses |
| 01/24/2008 | WO2008010448A1 Novel crystal of substituted phenylalkanoic acid and production process |
| 01/24/2008 | WO2008010428A1 Immunomodulating agent |
| 01/24/2008 | WO2008010335A1 Plant extract having arthritis-preventive effect |
| 01/24/2008 | WO2008010225A2 Enhancement of regulatory t cells' activity using statins |
| 01/24/2008 | WO2008009894A2 Use of imino sugars in immunotherapy |
| 01/24/2008 | WO2008009545A1 Anti-nkg2a antibodies and uses thereof |
| 01/24/2008 | WO2008009476A2 Concentrated methotrexate solutions |
| 01/24/2008 | WO2008009458A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | WO2008009426A1 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases |
| 01/24/2008 | WO2007139948A3 Imidazoazepinone compounds |
| 01/24/2008 | WO2007139921A3 N-oxides of kappa opioid receptor peptides |
| 01/24/2008 | WO2007137984A3 Modified humanised anti-interleukin-18 antibodies |
| 01/24/2008 | WO2007135172A3 Cladribine regimen for treating multiple sclerosis |
| 01/24/2008 | WO2007122156A9 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists |
| 01/24/2008 | WO2007001975A8 Piperidine derivatives useful as histamine h3 antagonists |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021211 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 01/24/2008 | US20080021099 5-Cyano-prostacyclin derivatives as agents for the treatment of autoimmune disease |
| 01/24/2008 | US20080021081 e.g. 4'-2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}cyclopropyl)-1,1'-biphenyl-4-carbonitrile; histamine-3 receptor ligand; neuroleptic agent, neurodegenerative diseases, cognition activator; attention-deficit hyperactivity disorder, schizophrenia, Alzheimer's disease, epilepsy, seizures, allergic rhinitis |
| 01/24/2008 | US20080021070 Pyridine derivatives, preparation and therapeutic application thereof |
| 01/24/2008 | US20080021069 Receptor Function Regulating Agent |
| 01/24/2008 | US20080021062 Alkylsulphonamide Quinolines |
| 01/24/2008 | US20080021061 Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity |
| 01/24/2008 | US20080021058 Pyrazolo '3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) Inhibitors |
| 01/24/2008 | US20080021057 3-Trifluoromethyl,6-((3-(methyl,4-hydroxytetrahydropyran-4-yl)-amino-(3-isopropyl-cyclopent-1,3-ylene))-carbonyl-)-5,6,7,8-tetrahydro-1,6-naphthyridine; antiinflammatory agents; immunomodulators; antiallergens; rhintis; dermatitis; conjunctivits, asthma; autoimmune diseases; antiarthritis agents |
| 01/24/2008 | US20080021038 Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5 |
| 01/24/2008 | US20080021037 Isethionate salt of a selective cdk4 inhibitor |
| 01/24/2008 | US20080021033 Immuno Inhibitory Heterocyclic Compounds |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
| 01/24/2008 | US20080021019 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds |
| 01/24/2008 | US20080020991 Methods of Treating, Reducing, or Preventing Autoimmune Conditions |
| 01/24/2008 | US20080020985 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020372 Methods for Detecting and Treating Cancer |
| 01/24/2008 | US20080020055 Phenylephrine Pharmaceutical Formulations and Compositions for Colonic Absorption |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080019996 Mushroom extracts having anticancer activity |
| 01/24/2008 | US20080019993 Inhibition of tumour growth |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019982 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction |
| 01/24/2008 | US20080019975 Novel Regimens for Treating Diseases and Disorders |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |
| 01/24/2008 | US20080019950 Novel hepatocyte-like cells and hepatoblast-like cells derived from hBS cells |
| 01/24/2008 | US20080019943 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 01/24/2008 | DE10047272B4 Verfahren zur Fusion von dendritischen Zellen mit erkrankten Gewebezellen, insbesondere Tumorzellen Methods for the fusion of dendritic cells with diseased tissue cells, particularly tumor cells |
| 01/24/2008 | CA2659662A1 Concentrated methotrexate solutions |
| 01/24/2008 | CA2658382A1 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases |
| 01/24/2008 | CA2658274A1 Use of soluble cd160 to suppress immunity |
| 01/24/2008 | CA2658190A1 Di-amino-substituted heterocyclic compounds and methods of use |
| 01/24/2008 | CA2657935A1 Antagonists of protease activated receptor-1 (par1) |
| 01/24/2008 | CA2657716A1 Cholanic acid amides |
| 01/24/2008 | CA2657260A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 01/24/2008 | CA2655623A1 Anti-nkg2a antibodies and uses thereof |
| 01/23/2008 | EP1881075A1 Retroviral vectors having a reduced recombination rate |
| 01/23/2008 | EP1881065A1 DINO polypetide |
| 01/23/2008 | EP1881007A1 LLR-J24 related proteins |
| 01/23/2008 | EP1880737A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 01/23/2008 | EP1880735A2 Vaccine |
| 01/23/2008 | EP1880729A1 Use of soluble CD160 to suppress immunity |
| 01/23/2008 | EP1880726A1 Immune function modulating agents |
| 01/23/2008 | EP1879908A1 Immunoglobulin fraction and process therefor |
| 01/23/2008 | EP1879604A2 Pif tetrapeptides |
| 01/23/2008 | EP1879600A2 Nanotubes as mitochondrial uncouplers |
| 01/23/2008 | EP1879585A1 Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis |
| 01/23/2008 | EP1879448A2 Compositions and methods related to serpin spi6 |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1141315B1 Modified hiv env polypeptides |
| 01/23/2008 | CN101111514A Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response |
| 01/23/2008 | CN101111495A Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 01/23/2008 | CN101111265A Synergistic combination of xolair/omalizumab/e25 with immunosuppressive agent |
| 01/23/2008 | CN101111259A Antilymphocyte antibody induction by combination of an s1p receptor agonist/modulator and of immunosuppressive drugs |
| 01/23/2008 | CN101111243A Classes of compounds that interact with integrins |
| 01/23/2008 | CN101111234A Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders |
| 01/23/2008 | CN101108250A Mono- and disaccharide derivatives |
| 01/23/2008 | CN101108246A Thymus gland pentapeptide oral intestine-dissolved formulated product and method of preparing the same and use thereof |
| 01/23/2008 | CN101108227A Konjak extractive powder capsule |
| 01/23/2008 | CN101108203A Radix astragali particle for preventing cold |
| 01/23/2008 | CN101108196A Method of producing glossy ganoderma polypeptide product |
| 01/23/2008 | CN101108195A Medicament for curing tumour, improving immunity of organism and method of manufacturing the same |
| 01/23/2008 | CN101108190A Application of cryptotanshinone in preparation of medicine preventing and controlling autoimmune disease |
| 01/23/2008 | CN101108176A Treating smooth muscle hyperactivity with (R)-oxybutynin and (R)- desethyloxybutynin |